Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine

PURPOSE: To compare treatment adherence, discontinuation, add-on, and daily average consumption (DACON) among adults with attention-deficit/hyperactivity disorder receiving second-line lisdexamfetamine dimesylate (LDX) or atomoxetine (ATX), following methylphenidate. PATIENTS AND METHODS: A retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Alain, Cloutier, Martin, Guérin, Annie, Nitulescu, Roy, Sikirica, Vanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818045/
https://www.ncbi.nlm.nih.gov/pubmed/27069357
http://dx.doi.org/10.2147/PPA.S98498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818045/
https://www.ncbi.nlm.nih.gov/pubmed/27069357
http://dx.doi.org/10.2147/PPA.S98498

Ejemplares similares